Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Acquisition Should Increase Routine Flow Cytometry Diagnostic Use in Research and Clinical Practice

By BiotechDaily International staff writers
Posted on 13 Aug 2013
Image: The MoFlo XDP flow cytometer has set the standard for cell sorting with functionality, speed, and improved sensitivity (Photo courtesy of Beckman Coulter Life Sciences).
Image: The MoFlo XDP flow cytometer has set the standard for cell sorting with functionality, speed, and improved sensitivity (Photo courtesy of Beckman Coulter Life Sciences).
A major American producer of instruments for biomedical testing has acquired access to flow cytometry reagents that were among the first of this genre to be both dry and temperature-stable with CE marking for routine in vitro diagnostic use in Europe.

Beckman Coulter Life Sciences (Indianapolis, IN, USA), which develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing has acquired the flow cytometry business assets of the life science technology company ReaMetrix India Pvt. Ltd. (Bangalore, India).

Beckman Coulter Life Sciences' diagnostic systems are found in hospitals and other critical care settings around the world and generate data used by physicians to diagnose disease, make treatment decisions, and monitor patients. In the research sector, their instruments have been applied to complex biological problems including causes of disease and potential new therapies or drugs. Acquisition of ReaMetrix is expected to help Beckman Coulter to widen its tool and technology offerings that would simplify the sample preparation process and provide highly standardized reagent combinations to cytometry laboratories around the globe. The deal provides it with temperature-stable, single-dose, multi-color antibody cocktails targeting two key segments for flow cytometry - HIV monitoring and clinical research.

“This acquisition provides both immediate opportunity and long-term value,” said Mario Koksch, vice president and general manager of the cytometry business unit at Beckman Coulter Life Sciences. “The simplification of customer workflows will be dramatic. We will be able to offer customers an extended line of market leading technology while expanding our reach within two key segments for flow cytometry—HIV monitoring and clinical research.”

“Over the last decade, ReaMetrix has been developing technologies that improve access of diagnostic testing through innovation,” said Bala S. Manian, CEO of ReaMetrix India Pvt. Ltd. “The development of room temperature stable unitized flow reagents used in diagnostics and life sciences is an important component of that effort. For ReaMetrix, Beckman Coulter Life Sciences represents an opportunity to provide the global customer with an integrated and optimized solution involving both hardware and reagents. From our point of view, we now have the best chance of benefiting the intended target population as well as impacting the productivity of cytometrists around the world. ”

Related Links:
Beckman Coulter Life Sciences
ReaMetrix India Pvt. Ltd.


RANDOX LABORATORIES
BIOSIGMA S.R.L.
SLAS - Society for Laboratory Automation and Screening
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel

e-Incubator Technology Provides Real-Time Imaging of Bioengineered Tissues in a Controlled Unit

A new e-incubator, an innovative miniature incubator that is compatible with magnetic resonance imaging (MRI), enables scientists to grow tissue-engineered constructs under a controlled setting and to study their growth and development in real time without risk of contamination or damage. Offering the potential to test... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.